Use of the 51Chromium Release Test to Demonstrate Antigenic Differences Between Extracellular and Intracellular Forms of Vaccinia Virus
- 1 October 1979
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 45 (1) , 65-72
- https://doi.org/10.1099/0022-1317-45-1-65
Abstract
Complement-dependent antibody lysis of vaccinia-infected [baby hamster kidney BHK-2d] cells was examined to demonstrate the antigenic differences between extracellular (ECV) and intracellular (ICV) forms of vaccinia virus. Cytolytic antibodies present in the antisera raised against ECV or live virus (LV) were completely removed by absorption with infected cell membranes or purified ECV but not with purified ICV. Absorption with infected cell membranes also abolished the neutralizing activity of ECV and LV antisera against ECV. Antiserum against ICV did not contain cytolytic antibodies against vaccinia-infected cells, even though its neutralizing antibody titer against ICV was high. Both ECV and ICV antisera neutralized a small proportion of the heterologous form of virus, despite using purified preparations of ECV and ICV, respectively, for raising these antisera in rabbits. The 51Cr release test only detected the antibodies against ECV, and thus can be used to differentiate between the antibody activity of a serum against ECV and ICV.This publication has 4 references indexed in Scilit:
- Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virusInfection and Immunity, 1978
- Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytesThe Journal of Experimental Medicine, 1977
- Presence of Haemagglutinin in the Envelope of Extracellular Vaccinia Virus ParticlesJournal of General Virology, 1976
- QUANTITATIVE ASSAY OF LYTIC ACTION OF IMMUNE LYMPHOID CELLS ON 51CR-LABELLED ALLOGENEIC TARGET CELLS IN VITRO - INHIBITION BY ISOANTIBODY AND BY DRUGS1968